Compassionate use of cefiderocol to treat tissue infection caused by MDR-pseudomonas aeruginosa in a critically-ill patient

Compassionate use of cefiderocol to treat tissue infection caused by MDR-pseudomonas aeruginosa in a critically-ill patient

Bibliographic Details
Main Authors:	Juan Higuera Lucas, Cruz Soriano Cuesta, Sergio Gallego Zarzosa, Susana García Plaza, Raúl de Pablo Sánchez
Format:	Article
Language:	Spanish
Published:	Editorial Iku 2022-03-01
Series:	Revista Chilena de Anestesia
Subjects:	cefiderocol lactamasas metalo beta resistentes resistencia multidroga pseudomona spp.
Online Access:	https://revistachilenadeanestesia.cl/PII/revchilanestv5109021126.pdf

Similar Items

Prevalencia de metalo-β-lactamasas en Pseudomonas aeruginosa resistentes a carbapenemes en un Hospital Universitario de Buenos Aires
by: G. Pagniez, et al.

Perfil de resistencia a antibióticos en bacterias que presentan la enzima NDM-1 y sus mecanismos asociados: una revisión sistemática
by: Jeimmy Castañeda, et al.
Published: (2017-03-01)

Caracterización fenotípica y genotípica de la resistencia a imipenem en Pseudomonas aeruginosa aisladas en un hospital de Buenos Aires Phenotypic and genotypic characterization of imipenem-resistant Pseudomonas aeruginosa isolated in Buenos Aires
by: D. Cejas, et al.
Published: (2008-12-01)

Prevalencia de metalo-β-lactamasas en Pseudomonas aeruginosa resistentes a carbapenemes en un Hospital Universitario de Buenos Aires Prevalence of metallo-β-lactamase in carbapenem resistant Pseudomonas aeruginosa at an University Hospital of Buenos Aires City
by: G. Pagniez, et al.
Published: (2006-03-01)

Caracterização da tuberculose multidroga resistente durante a gravidez, em Campinas, Estado de São Paulo, Brasil, no período de 1995 a 2007
by: Helenice Bosco de Oliveira, et al.
Published: (2011-10-01)

Evaluación de métodos fenotípicos para la detección de metalobetalactamasas en aislados clínicos de Pseudomonas aeruginosa
by: Perozo-Mena Armindo José, et al.
Published: (2013-12-01)

New mutations in genes associated with cefiderocol resistance in a clinical isolate of Pseudomonas aeruginosa
by: Bocharova Yu.A., et al.
Published: (2023-12-01)

Evaluation of antibiofilm activity of cefiderocol alone and in combination with imipenem against Pseudomonas aeruginosa
by: Caterina Ferretti, et al.
Published: (2024-06-01)

SUSCETIBILIDADE DE CEFIDEROCOL ENTRE PSEUDOMONAS AERUGINOSA E COMPLEXO ACINETOBACTER BAUMANNII (CAB) EM HOSPITAL TERCIÁRIO DE PORTO ALEGRE
by: Deise Reis Carvalho, et al.
Published: (2023-10-01)

In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from cystic fibrosis patients
by: Marguerite L. Monogue, et al.
Published: (2023-12-01)

PREVALÊNCIA DA COLONIZAÇÃO OU INFECÇÃO POR ENTEROCOCCUS SPP RESISTENTES À VANCOMICINA DE PACIENTES INTERNADOS EM HOSPITAL TERCIÁRIO NO RECIFE-PE
by: Kledoaldo Oliveira de Lima, et al.
Published: (2023-10-01)

Diseminación de blaIMP-8 en enterobacterias aisladas en un hospital de Buenos Aires
by: Ana M Togneri, et al.

ISOLAMENTO E IDENTIFICAÇÃO DE BACTÉRIAS MULTIDROGA RESISTENTES ASSOCIADAS À PNEUMONIA EM BIOFILME ORAL DE INDIVÍDUOS NO MOMENTO DA INTERNAÇÃO EM UNIDADE DE TERAPIA INTENSIVA
by: Maite Rocha Conde, et al.
Published: (2023-10-01)

Carbapenem-resistant Pseudomonas aeruginosa producing NDM-1
by: Paulo Ricardo Freitag Jorge, et al.
Published: (2023-08-01)

Caracterización de metalo-β-lactamasas en aislados clínicos de Pseudomonas aeruginosa recuperados de pacientes hospitalizados en el Hospital Militar Central
by: Gina Salvador-Luján, et al.
Published: (2018-12-01)

An Assessment Of Cefiderocol's Synergistic Effects With Eravacycline, Colistin, Meropenem, Levofloxacin, Ceftazidime/Avibactam, And Tobramycin Against Carbapenem-Resistant Pseudomonas Aeruginosa
by: Bekir Özer, et al.
Published: (2024-12-01)

Cefiderocol for treatment of an empyema due to extensively drug-resistant Pseudomonas aeruginosa: Clinical observations and susceptibility testing considerations
by: Wesley D. Kufel, et al.
Published: (2020-01-01)

ANÁLISE COMPARATIVA DO DESEMPENHO DE UM SISTEMA DE QPCR IN HOUSE COM INSUMOS NACIONAIS PARA INVESTIGAÇÃO DA RESISTÊNCIA DE CEPAS MYCOBACTERIUM TUBERCULOSIS DROGAS RESISTENTES
by: Wlisses Henrique Veloso de Carvalho Silva, et al.
Published: (2023-10-01)

Performance of disc diffusion and E-test on different Muller-Hinton agar media plates and ComASPⓇ and Bruker UMICⓇ Cefiderocol Microdilution Panels for Cefiderocol susceptibility testing in carbapenem-resistant Pseudomonas aeruginosa
by: Stefano Mancini, et al.
Published: (2024-12-01)

Utilidad de la citometría de flujo para la detección de Pseudomonas aeruginosa productoras de metalobetalactamasas
by: Iván Alexander Salinas-Salcedo, et al.
Published: (2020-11-01)

PERFIL DE SUSCEPTIBILIDADE AOS ANTIMICROBIANOS DE ISOLADOS DE ESCHERICHIA COLI E KLEBSIELLA PNEUMONIAE IDENTIFICADOS EM INFECÇÕES DO TRATO URINÁRIO ADQUIRIDAS NA COMUNIDADE
by: Vívian Santos Galvão, et al.
Published: (2023-10-01)

Klebsiella pneumoniae New Delhi Metalo-Lactamase in a Peruvian national hospital
by: Cristhian Resurrección-Delgado, et al.
Published: (2017-06-01)

IMPACTO DA PANDEMIA DE CORONAVÍRUS (COVID-19) SOBRE INFECÇÕES RELACIONADAS À ASSISTÊNCIA À SAÚDE EM UM HOSPITAL DE ENSINO
by: Helena Alvarenga Sardenberg, et al.
Published: (2023-10-01)

Comparison of Different Methods for Assaying the In Vitro Activity of Cefiderocol against Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Strains: Influence of Bacterial Inoculum
by: Celia García-Rivera, et al.
Published: (2024-07-01)

Detección del gen codificante de la metalo-ß-lactamasa VIM-2 en un integrón de clase 1 asociado con el gen blaCTX-M-2 en un aislamiento clínico de Pseudomonas aeruginosa en el Uruguay: primera comunicación
by: Ana J Ingold, et al.
Published: (2011-09-01)

In vitro activity assessment of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., including β-lactam nonsusceptible molecularly characterized isolates, collected from 2020 to 2021 in the United States and European hospitals
by: John H. Kimbrough, et al.
Published: (2024-11-01)

Mecanismos de resistencia en Pseudomonas aeruginosa: entendiendo a un peligroso enemigo
by: Carlos Andrés Gómez Álvarez, et al.
Published: (2005-01-01)

Rapid development of cefiderocol resistance in a carbapenem-resistant Pseudomonas aeruginosa isolate associated with mutations in the pyoverdine biosynthesis pathway
by: Luise Brakert, et al.
Published: (2023-09-01)

Antimicrobial Activity of Ceftolozane-Tazobactam, Ceftazidime-Avibactam, and Cefiderocol against Multidrug-Resistant Pseudomonas aeruginosa Recovered at a German University Hospital
by: C. Weber, et al.
Published: (2022-10-01)

Novel PiuC, PirA, and PiuA mutations leading to in vivo cefiderocol resistance progression in IMP-16- and KPC-2-producing Pseudomonas aeruginosa from a leukemic patient
by: Joaquim Viñes, et al.
Published: (2025-03-01)

Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data
by: Giacobbe DR, et al.
Published: (2020-12-01)

The Efficacy of Topical Cefiderocol Treatment of Experimental Extensively Drug-Resistant <i>Pseudomonas aeruginosa</i> Keratitis Is Dependent upon the State of the Corneal Epithelium
by: Eric G. Romanowski, et al.
Published: (2024-10-01)

Resistencia antibiótica en bacilos gram negativos, cocáceas gram positivas y anaerobios. implicancias terapéuticas
by: C. Alberto Fica, Dr.
Published: (2014-05-01)

Ocorrência de cepas de Pseudomonas aeruginosa multirresistentes produtoras de metalo-β-lactamase blaSPM-1 em amostras clínicas Occurrence of multiresistant strains of Pseudomonas aeruginosa producing metallo-β-lactamase blaSPM-1 in clinical samples
by: Tiago Gräf, et al.
Published: (2008-06-01)

Valor actual de la gammagrafía de mamas mediante 99mTc-sestamibi en la práctica oncológica
by: René F. Cárdenas, et al.
Published: (2022-09-01)

Paciente VIH positivo con tuberculosis sistémica y lesiones osteolíticas de la calvaria, semejando mieloma múltiple
by: Victor Mechán, et al.
Published: (2010-07-01)

Electrochemical detection of cefiderocol for therapeutic drug monitoring
by: James McLeod, et al.
Published: (2021-12-01)

ATIVIDADE IN VITRO DE NOVOS ANTIMICROBIANOS/COMBINAÇÕES CONTRA ISOLADOS CLÍNICOS DE KLEBSIELLA E PSEUDOMONAS RESISTENTES AOS CARBAPENÊMICOS
by: Carlos Henrique Camargo, et al.
Published: (2023-10-01)

ALTAS TAXAS DE BACTÉRIAS MULTIRRESISTENTES NAS INFECÇÕES RELACIONADAS ÀS FRATURAS: MUDANÇA DO CENÁRIO EPIDEMIOLÓGICO
by: Daniel Litardi Castorino Pereira, et al.
Published: (2023-10-01)

In vitro pharmacokinetics of cefiderocol alone and in combination with antibiotics against Achromobacter spp. and Stenotrophomonas maltophilia species
by: Gokce Konyaoglu, et al.
Published: (2024-12-01)